v3.25.2
Condensed Consolidated Statements of Cash Flows - CHF (SFr)
SFr in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities    
Loss for the period SFr (40,218) SFr (40,622)
Adjustments to reconcile net loss for the period to net cash flows:    
Depreciation of property, plant and equipment 724 767
Depreciation of right-of-use assets 511 337
Finance (income), net 1,239 110
Share-based compensation expense 2,679 3,277
Change in net employee defined benefit liability 192 98
Interest expense 102 68
(Gain)/loss on sale of fixed assets (15)  
Changes in working capital:    
(Increase)/decrease in prepaid expenses 1,760 2,574
(Increase)/decrease in accrued income 589 (156)
(Increase)/decrease in accounts receivable   14,800
(Increase)/decrease in other current receivables (450) (510)
(Decrease)/increase in accrued expenses (620) 1,328
(Decrease)/increase in deferred contract revenue, short-term (1,331) 86,468
(Decrease)/increase in deferred income   (93)
(Decrease)/increase in trade and other payables 242 (246)
(Decrease)/increase in deferred contract revenue, long-term (964) 5,170
Cash provided by/(used in) operating activities (35,560) 73,370
Interest received 1,250 749
Interest paid (94) (60)
Finance expenses paid (10) (8)
Net cash flows provided by/(used in) operating activities (34,414) 74,051
Investing activities    
(Deposits)/maturities of short-term financial assets, net 27,801 (99,006)
Purchases of property, plant and equipment (735) (317)
Proceeds from sale of property, plant and equipment 15  
Rental deposits (170) (54)
Net cash flows provided by/(used in) investing activities 26,911 (99,377)
Financing activities    
Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs   131
Proceeds from issuance of common shares - equity plan, net of transaction costs 1  
Proceeds from issuance of common shares - option plan, net of transaction costs 2 6
Transaction costs and stamp duty associated with the public offerings of common shares previously recorded in Accrued expenses   (521)
Transaction costs associated with the sale of treasury shares in public offering previously recorded in Accrued expenses   (26)
Principal payments of lease obligations (508) (340)
Net cash flows (used in) financing activities (505) (750)
Net (decrease) in cash and cash equivalents (8,008) (26,076)
Cash and cash equivalents at beginning of period 36,275 78,494
Exchange gain/(loss) on cash and cash equivalents (2,545) (854)
Cash and cash equivalents at end of the period 25,722 51,564
Supplemental non-cash activity    
Transaction costs associated with the sale of treasury shares in public offering recorded in Accrued expenses   26
Capital expenditures in Trade and other payables or Accrued expenses SFr 3 SFr 24